WHO Issues Alert Regarding Counterfeit JAKAVI Medication
The World Health Organization has released a Medical Product Alert concerning falsified versions of JAKAVI (ruxolitinib), a drug used to treat certain blood disorders. This warning addresses a critical patient safety concern, as these counterfeit medicines can be ineffective or potentially harmful to those who use them.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.